UC Irvine-led study links biomarkers and chemotherapy-related gastrointestinal symptoms
A study led by University of California, Irvine researchers has revealed a connection between blood levels of omega-3 and the inflammatory biomarker interleukin
Stay updated with breaking news from Pharmaceutical Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A study led by University of California, Irvine researchers has revealed a connection between blood levels of omega-3 and the inflammatory biomarker interleukin
<p>Researchers have identified a receptor protein known as CHRM1 as a key player in prostate cancer cells’ resistance to docetaxel, a commonly used chemotherapy drug to treat advanced cancer that has spread beyond the prostate. The study showed that using the drug dicyclomine to block CHRM1 in resistant prostate cancer cell lines and an animal model based on patient-derived resistant tissue restored docetaxel’s ability to kill cells and stop tumor growth. Dicyclomine is already on the market as a drug to treat symptoms of inflammatory bowel syndrome. The discovery ope...
Nevada now boasts more than 9,400 jobs across 1,000 biotech companies statewide.
New WSU research could ultimately help extend the lives of those with prostate cancer, one of the leading causes of cancer deaths among men.
Researchers have identified a receptor protein known as CHRM1 as a key player in prostate cancer cells' resistance to docetaxel, a commonly used chemotherapy drug to treat advanced cancer that has spread beyond the prostate.